Mitochondrial DNA Heteroplasmy Associations With Neurosensory and Mobility Function in Elderly Adults

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 70, Issue 11, 2015, Pages 1418-1424

  Tranah, Gregory J ^a,b   Yaffe, Kristine ^b,c   Katzman, Shana M ^d   Lam, Ernest T ^e   Pawlikowska, Ludmila ^b,f   Kwok, Pui Yan ^b   Schork, Nicholas J ^g   Manini, Todd M ^h   Kritchevsky, Stephen ⁱ   Thomas, Fridtjof ^j   Newman, Anne B ^k   Harris, Tamara B ^l   Coleman, Anne L ^m   Gorin, Michael B ^m   Helzner, Elizabeth P ⁿ   Rowbotham, Michael C ^a   Browner, Warren S ^a   Cummings, Steven R ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d LA Eye Center and Clinic   (United States)

^e USA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF FLORIDA   (United States)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^k UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^l NATIONAL INSTITUTE ON AGING   (United States)

^m JULES STEIN EYE INSTITUTE   (United States)

ⁿ SUNY DOWNSTATE MEDICAL CENTER   (United States)

more..

Author keywords

Cognition; Hearing; Heteroplasmy; Mitochondrial DNA; Mobility; Vision

Indexed keywords

MITOCHONDRIAL DNA;

AGED; COGNITIVE DEFECT; COHORT ANALYSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; GENETICS; HUMAN; MALE; NEUROLOGIC GAIT DISORDER; SENSORY DYSFUNCTION; WALKING DIFFICULTY;

AGED; COGNITION DISORDERS; COHORT STUDIES; DNA, MITOCHONDRIAL; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; MALE; MITOCHONDRIAL DISEASES; MOBILITY LIMITATION; SENSATION DISORDERS;

EID: 84946594769     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glv097     Document Type: Article

References (54)

1. Payne BA, Wilson IJ, Yu-Wai-Man P, et al. Universal heteroplasmy of human mitochondrial DNA. Hum Mol Genet. 2013;22:384-390. doi:10.1093/hmg/dds435
2. Naviaux RK. Mitochondrial DNA disorders. Eur J Pediatr. 2000;159(suppl 3):S219-S226. doi:10.1007/PL00014407
3. MITOMAP: A Human Mitochondrial Genome Database. http://www.mitomap.org. Accessed February 15, 2015.
4. Linnane AW, Marzuki S, Ozawa T, Tanaka M. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet. 1989;1:642-645. doi:http://dx.doi.org/10.1016/S0140-6736(89)92145-4
5. Arnheim N, Cortopassi G. Deleterious mitochondrial DNA mutations accumulate in aging human tissues. Mutat Res. 1992;275:157-167. doi:10.1016/0921-8734(92)90020-P
6. Trounce I, Byrne E, Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet. 1989;1:637-639. doi:http://dx.doi.org/10.1016/S0140-6736(89)92143-0
7. Tyrrell DJ, Bharadwaj MS, Van Horn CG, Kritchevsky SB, Nicklas BJ, Molina AJ. Respirometric profiling of muscle mitochondria and blood cells are associated with differences in gait speed among community-dwelling older adults. J Gerontol A Biol Sci Med Sci. July 16, 2014. doi:10.1093/gerona/glu096. pii:glu096. [Epub ahead of print].
8. Van Remmen H, Jones DP. Current thoughts on the role of mitochondria and free radicals in the biology of aging. J Gerontol A Biol Sci Med Sci. 2009;64:171-174. doi:10.1093/gerona/gln058
9. Figueiredo PA, Powers SK, Ferreira RM, Appell HJ, Duarte JA. Aging impairs skeletal muscle mitochondrial bioenergetic function. J Gerontol A Biol Sci Med Sci. 2009;64:21-33. doi:10.1093/gerona/gln048
10. Menshikova EV, Ritov VB, Fairfull L, Ferrell RE, Kelley DE, Goodpaster BH. Effects of exercise on mitochondrial content and function in aging human skeletal muscle. J Gerontol A Biol Sci Med Sci. 2006;61:534-540. doi:10.1093/gerona/61.6.534
11. Horan MP, Pichaud N, Ballard JW. Review: quantifying mitochondrial dysfunction in complex diseases of aging. J Gerontol A Biol Sci Med Sci. 2012;67:1022-1035. doi:10.1093/gerona/glr263
12. Lebre AS, Rio M, Faivre d'Arcier L, et al. A common pattern of brain MRI imaging in mitochondrial diseases with complex I deficiency. J Med Genet. 2011;48:16-23. doi:10.1136/jmg.2010.079624
13. Tranah GJ, Lam ET, Katzman SM, et al.; Health, Aging and Body Composition Study. Mitochondrial DNA sequence variation is associated with free-living activity energy expenditure in the elderly. Biochim Biophys Acta. 2012;1817:1691-1700. doi:10.1016/j.bbabio.2012.05.012
14. Coon KD, Valla J, Szelinger S, et al. Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing. Mitochondrion. 2006;6:194-210. doi:10.1016/j.mito.2006.07.002
15. Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30:81-114. doi:10.1016/j.preteyeres.2010.11.002
16. Ye K, Lu J, Ma F, Keinan A, Gu Z. Extensive pathogenicity of mitochondrial heteroplasmy in healthy human individuals. Proc Natl Acad Sci U S A. 2014;111:10654-10659. doi:10.1073/pnas.1403521111
17. Cesari M, Kritchevsky SB, Nicklas B, et al. Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the Health Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci. 2012;67A:671-676. doi:10.1093/gerona/glr246
18. Smeitink J, van den Heuvel L, Di Mauro S. The genetics and pathology of oxidative phosphorylation. Nat Rev Genet. 2001;2:342-352. doi:10.1038/35072063
19. Loeffen JL, Smeitink JA, Trijbels JM, et al. Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat. 2000;15:123-134. doi:10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.0.CO;2-P
20. Zifa E, Giannouli S, Theotokis P, Stamatis C, Mamuris Z, Stathopoulos C. Mitochondrial tRNA mutations: clinical and functional perturbations. RNA Biol. 2007;4:38-66. doi:10.4161/rna.4.1.4548
21. Hao H, Moraes CT. A disease-associated G5703A mutation in human mitochondrial DNA causes a conformational change and a marked decrease in steady-state levels of mitochondrial tRNA(Asn). Mol Cell Biol. 1997;17:6831-6837.
22. Guan MX, Enriquez JA, Fischel-Ghodsian N, et al. The deafnessassociated mitochondrial DNA mutation at position 7445, which affects tRNASer(UCN) precursor processing, has long-range effects on NADH dehydrogenase subunit ND6 gene expression. Mol Cell Biol. 1998;18:5868-5879.
23. McFarland R, Kirby DM, Fowler KJ, et al. De novo mutations in the mitochondrial ND3 gene as a cause of infantile mitochondrial encephalopathy and complex I deficiency. Ann Neurol. 2004;55:58-64. doi:10.1002/ana.10787
24. Guy J, Feuer WJ, Porciatti V, et al. Retinal ganglion cell dysfunction in asymptomatic G11778A: Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2014;55:841-848. doi:10.1167/iovs.13-13365
25. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988;242:1427-1430. doi:10.1126/science.3201231
26. Giordano C, Montopoli M, Perli E, et al. Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. Brain. 2011;134(Pt 1):220-234. doi:10.1093/brain/awq276
27. Wong A, Cavelier L, Collins-Schramm HE, et al. Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells. Hum Mol Genet. 2002;11:431-438.
28. Baracca A, Solaini G, Sgarbi G, et al. Severe impairment of complex I-driven adenosine triphosphate synthesis in leber hereditary optic neuropathy cybrids. Arch Neurol. 2005;62:730-736. doi:10.1001/archneur. 62.5.730
29. Ghelli A, Zanna C, Porcelli AM, et al. Leber's hereditary optic neuropathy (LHON) pathogenic mutations induce mitochondrial-dependent apoptotic death in transmitochondrial cells incubated with galactose medium. J Biol Chem. 2003;278:4145-4150.
30. Zanna C, Ghelli A, Porcelli AM, Carelli V, Martinuzzi A, Rugolo M. Apoptotic cell death of cybrid cells bearing Leber's hereditary optic neuropathy mutations is caspase independent. Ann N Y Acad Sci. 2003;1010:213-217. doi:10.1196/annals.1299.037
31. Hudson G, Keers S, Yu Wai Man P, et al. Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. Am J Hum Genet. 2005;77:1086-1091. doi:http://dx.doi.org/10.1086/498176
32. Hudson G, Carelli V, Spruijt L, et al. Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. Am J Hum Genet. 2007;81:228-233. doi:http://dx.doi.org/10.1086/519394
33. Qi X, Sun L, Hauswirth WW, Lewin AS, Guy J. Use of mitochondrial antioxidant defenses for rescue of cells with a Leber hereditary optic neuropathy-causing mutation. Arch Ophthalmol. 2007;125:268-272. doi:10.1001/archopht.125.2.268
34. Hao H, Morrison LE, Moraes CT. Suppression of a mitochondrial tRNA gene mutation phenotype associated with changes in the nuclear background. Hum Mol Genet. 1999;8:1117-1124. doi:10.1093/hmg/8.6.1117
35. Russell O, Turnbull D. Mitochondrial DNA disease-molecular insights and potential routes to a cure. Exp Cell Res. 2014;325:38-43. doi:10.1016/j. yexcr.2014.03.012
36. Taylor RW, Chinnery PF, Turnbull DM, Lightowlers RN. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet. 1997;15:212-215. doi:10.1038/ng0297-212
37. Minczuk M, Papworth MA, Miller JC, Murphy MP, Klug A. Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA. Nucleic Acids Res. 2008;36:3926-3938. doi:10.1093/nar/gkn313
38. Comte C, Tonin Y, Heckel-Mager AM, et al. Mitochondrial targeting of recombinant RNAs modulates the level of a heteroplasmic mutation in human mitochondrial DNA associated with Kearns Sayre syndrome. Nucleic Acids Res. 2013;41:418-433. doi:10.1093/nar/gks965
39. Boch J, Scholze H, Schornack S, et al. Breaking the code of DNA binding specificity of TAL-type III effectors. Science. 2009;326:1509-1512. doi:10.1126/science
40. Rorbach J, Yusoff AA, Tuppen H, et al. Overexpression of human mitochondrial valyl tRNA synthetase can partially restore levels of cognate mt-tRNAVal carrying the pathogenic C25U mutation. Nucleic Acids Res. 2008;36:3065-3074. doi:10.1093/nar/gkn147
41. Dai Y, Zheng K, Clark J, et al. Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation. Hum Mol Genet. 2014;23:637-647. doi:10.1093/hmg/ddt450
42. Payne BA, Wilson IJ, Hateley CA, et al. Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations. Nat Genet. 2011;43:806-810. doi:10.1038/ng.863
43. Durham SE, Samuels DC, Chinnery PF. Is selection required for the accumulation of somatic mitochondrial DNA mutations in post-mitotic cells? Neuromuscul Disord. 2006;16:381-386. doi:http://dx.doi.org/10.1016/j. nmd.2006.03.012
44. Khrapko K, Nekhaeva E, Kraytsberg Y, Kunz W. Clonal expansions of mitochondrial genomes: implications for in vivo mutational spectra. Mutat Res. 2003;522:13-19. doi:10.1016/S0027-5107(02)00306-8
45. Stewart JB, Freyer C, Elson JL, et al. Strong purifying selection in transmission of mammalian mitochondrial DNA. PLoS Biol. 2008;6:e10. doi:10.1371/journal.pbio.0060010
46. Fan W, Waymire KG, Narula N, et al. A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science. 2008;319:958-962. doi:10.1126/science.1147786
47. Ross JM, Stewart JB, Hagstrom E, et al. Germline mitochondrial DNA mutations aggravate ageing and can impair brain development. Nature. 2013. doi:10.1038/nature12474
48. Elson JL, Samuels DC, Turnbull DM, Chinnery PF. Random intracellular drift explains the clonal expansion of mitochondrial DNA mutations with age. Am J Hum Genet. 2001;68:802-806. doi:http://dx.doi.org/10.1086/318801
49. Ozawa T. Mechanism of somatic mitochondrial DNA mutations associated with age and diseases. Biochim Biophys Acta. 1995;1271:177-189. doi:10.1016/0925-4439(95)00026-Z
50. Crimi M, Papadimitriou A, Galbiati S, et al. A new mitochondrial DNA mutation in ND3 gene causing severe Leigh syndrome with early lethality. Pediatr Res. 2004;55:842-846. doi:10.1203/01.PDR.0000117844.73436.68
51. Lebon S, Chol M, Benit P, et al. Recurrent de novo mitochondrial DNA mutations in respiratory chain deficiency. J Med Genet. 2003;40:896-899. doi:10.1136/jmg.40.12.896
52. Pyle A, Taylor RW, Durham SE, et al. Depletion of mitochondrial DNA in leucocytes harbouring the 3243A->G mtDNA mutation. J Med Genet. 2007;44:69-74. doi:10.1136/jmg.2006.043109
53. Chinnery PF, Samuels DC. Relaxed replication of mtDNA: a model with implications for the expression of disease. Am J Hum Genet. 1999;64:1158-1165. doi:10.1086/302311
54. Catricala S, Torti M, Ricevuti G. Alzheimer disease and platelets: how's that relevant. Immun Ageing. 2012;9:20. doi:10.1186/1742-4933-9-20